Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03753243
Brief Title: Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

First Submitted : November 20, 2018
First Submitted that Met QC Criteria : November 21, 2018
First Posted : November 26, 2018

Last Update Submitted that Met QC Criteria : August 28, 2019
Last Update Posted : August 30, 2019